Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Mitigating Hunger and Food Insecurity Among Socioeconomically Disadvantaged Caregivers of Hospitalized Children

Not Applicable

Withdrawn

Conditions: Health Behavior

Interventions: Other: Feed1st

First Posted Date: 2016-03-07

Last Posted Date: 2017-05-12

Lead Sponsor: University of Chicago

Registration Number: NCT02700802

Serial Endoscopic Surveillance & Direct Topical Antibiotics to Define the Role of Microbes in Anastomotic Healing

Phase 2

Withdrawn

Conditions: Anastomotic Leak
Rectal Cancer

Interventions: Drug: Cipro, metronidazole, neomycin combo
Procedure: Serial Endoscopic Surveillance
Drug: Saline

First Posted Date: 2016-02-15

Last Posted Date: 2023-04-26

Lead Sponsor: University of Chicago

Registration Number: NCT02682485

Public Health Targeting of PrEP at HIV Positives' Bridging Networks

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: PrEP Intervention

First Posted Date: 2016-02-08

Last Posted Date: 2020-01-09

Lead Sponsor: University of Chicago

Target Recruit Count: 308

Registration Number: NCT02676167

Locations: 🇬🇷
Angelos Hatzakis, Athens, Greece

Remediating Academic Skill Deficits Among Disadvantaged Youth

Not Applicable

Conditions: Educational Achievement

Interventions: Other: SAGA Innovations

First Posted Date: 2016-02-04

Last Posted Date: 2017-07-11

Lead Sponsor: University of Chicago

Target Recruit Count: 1848

Registration Number: NCT02673645

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Phase 1

Withdrawn

Conditions: Malignant Pleural Mesothelioma (MPM)

Interventions: Biological: Multipeptide vaccine S-588210

First Posted Date: 2016-01-22

Last Posted Date: 2018-05-14

Lead Sponsor: University of Chicago

Registration Number: NCT02661659

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma

Phase 3

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Lenalidomide (Control)
Drug: Lenalidomide
Drug: Carfilzomib
Drug: Dexamethasone

First Posted Date: 2016-01-20

Last Posted Date: 2024-08-15

Lead Sponsor: University of Chicago

Target Recruit Count: 180

Registration Number: NCT02659293

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Wayne State University - Karmanos Cacner Institute, Detroit, Michigan, United States
🇵🇱
Polish Myeloma Consortium, Poznań, Poland

Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology

Not Applicable

Completed

Conditions: Depression

Interventions: Drug: Placebo
Drug: 0.2mg Buprenorphine

First Posted Date: 2016-01-20

Last Posted Date: 2019-05-29

Lead Sponsor: University of Chicago

Target Recruit Count: 38

Registration Number: NCT02659787

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

HealtheRx Survey for Pulmonary Research Registry Recruitment

Not Applicable

Completed

Conditions: COPD
Asthma

Interventions: Other: HealtheRx+
Other: HealtheRx++

First Posted Date: 2016-01-12

Last Posted Date: 2020-04-29

Lead Sponsor: University of Chicago

Target Recruit Count: 41

Registration Number: NCT02653066

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients

Phase 2

Terminated

Conditions: Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)

Interventions: Biological: Haplo-Cord Transplant
Procedure: Matched Unrelated Donor Transplant

First Posted Date: 2016-01-07

Last Posted Date: 2021-03-18

Lead Sponsor: University of Chicago

Target Recruit Count: 9

Registration Number: NCT02648932

Locations: 🇺🇸
University of Chicago Cancer Center, Chicago, Illinois, United States

Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation

Not Applicable

Active, not recruiting

Conditions: Pregnancy
Child Development

Interventions: Dietary Supplement: DHA
Dietary Supplement: Sugar pill

First Posted Date: 2016-01-06

Last Posted Date: 2024-07-25

Lead Sponsor: University of Chicago

Target Recruit Count: 168

Registration Number: NCT02647723

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy